Arkolith/Insider Trading/BCLI/Form 4/A

Lebovits Chaim

President & CEOBRAINSTORM CELL THERAPEUTICS INC. (BCLI) · full profile →Form 4/A · filed Jul 31, 2024
Net Buying
Open-Market Buys
$19K
Open-Market Sells
$0
Net Open-Market Flow
$19K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 13, 2024Buy(P)10K$0.49$5K1.1M
May 11, 2024Buy(P)10K$0.47$5K1.1M
May 10, 2024Buy(P)20K$0.47$9K1.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001104659-24-084341) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML